OM1 Secures $15 Million Series A Funding to Advance AI-Powered Healthcare Data Analytics Platform

OM1 (formerly Better Outcomes) is a medical outcomes analytics company,Headquartered in Boston, Massachusetts, USA. Recently, the company has obtainedLed by General Catalyst,Glikvest, 7wire Ventures, and Wanxiang Healthcare Investment Co. participated as follow-on investorsSeries A financing of $15 million.

Details of this round of investment. Data source: Crunchbase

The company plans to use the funds to build a technology platform leveraging big data and artificial intelligence (AI), providing stakeholders with an analytical platform that offers a comprehensive perspective and deeper understanding of real-world medical outcomes, thereby facilitating better decision-making.

According to VCBeat, OM1Founded in 2015, itsFounder and CEO: Rich Gliklich.

OM1’s data analytics platform leverages comprehensive and rich clinical data to provide AI-driven analytical predictions, thereby enhancing hospitals’ clinical, financial, and operational management.

Beyond hospitals, healthcare providers are also actively seeking analytical insights that incorporate patient data to enable more precise care.Researchers in the life sciences sector aim to validate the efficacy and safety of their products using patient data. Meanwhile,Insurance companies,Including the federal government’s exploration of more value-based healthcare payment models.

OM1 has pioneered a robust clinical data analytics approach that leverages vast amounts of clinical data and artificial intelligence (AI) to deliver detailed analytical insights, enabling stakeholders across the entire healthcare ecosystem to access accurate information for better decision-making.

Furthermore, the system can help healthcare institutions better optimize patient rehabilitation services by leveraging intelligent decision-making to more clearly reflect the link between treatment outcomes and value.

Rich Gliklich, Founder and CEO of OM1, stated, “To improve the quality of care in healthcare institutions, we need to fundamentally understand real-world data outcomes and do better in predicting high-risk patients and evaluating potential treatment options.”

The system established by OM1 will provide healthcare institutions with insights into the relationship between care and outcomesUnprecedented Relationship Chains, helping them avoid high-cost events and ultimately deliver the best patient care.At the same time, we focus on helping researchers and payers understand real-world evidence more quickly and accurately, and better comprehend the link between data outcomes and healthcare value.”